Medicine
Lenalidomide 20 mg capsule
Lenalidomide 20 mg capsule is a generic prescription medicine for oral use, made by 17 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C - 25°C (68°F - 77°F), excursions permitted to 15°C - 30°C (59°F…
Key facts
- Active ingredient (INN)
- Lenalidomide
- Brand
- Sold under the generic name
- Strength
- 20 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 100 capsules, 21 capsules, 1 blister pack and 27 more
- Manufacturers
- Zydus LifesciencesIndiaAurobindo PharmaIndiaBioconIndiaCamber PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaSun Pharmaceutical IndustriesIndiaAccord HealthcareIndiaCiplaIndiaAlvogenAmneal Pharmaceuticals NY
- Origin register
- US FDA, United States
- Storage
- Store at 20°C - 25°C (68°F - 77°F), excursions permitted to 15°C - 30°C (59°F - 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L04AX04 Lenalidomide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 6 September 2022
- Identifiers
- RxCUI 602910, 602912, 643712 +3DailyMed set ID 9959cd7e-12b6-4b59-8205-d5f6e7e7d09b, 9c414531-a3bf-455a-aca7-9e716f42099a, 682e8a86-9f49-45db-a2ea-403ee1dc62d2 +15NDC 73043-042, 16729-696, 76282-700 +15Application ANDA217554, ANDA218872, ANDA210435 +13
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 capsule in 1 bottle | 70710-1034-1 | Zydus LifesciencesIndia | 7 March 2023 |
| 21 capsule in 1 bottle | 70710-1034-8 | Zydus LifesciencesIndia | 7 March 2023 |
| 100 capsule in 1 bottle | 70771-1680-1 | Zydus LifesciencesIndia | 7 March 2023 |
| 21 capsule in 1 bottle | 70771-1680-8 | Zydus LifesciencesIndia | 7 March 2023 |
| 21 capsule in 1 bottle | 16729-696-06 | Accord HealthcareIndia | 26 February 2026 |
| 100 capsule in 1 bottle | 59651-346-01 | Aurobindo PharmaIndia | 6 March 2023 |
| 1 blister pack in 1 carton / 7 capsule in 1 blister pack | 59651-346-07 | Aurobindo PharmaIndia | 6 March 2023 |
| 21 capsule in 1 bottle | 59651-346-21 | Aurobindo PharmaIndia | 6 March 2023 |
| 21 capsule in 1 bottle | 70377-053-11 | BioconIndia | 3 March 2025 |
| 100 capsule in 1 bottle | 70377-053-12 | BioconIndia | 3 March 2025 |
| 100 capsule in 1 bottle | 31722-261-01 | Camber PharmaceuticalsIndia | 11 May 2023 |
| 21 capsule in 1 bottle | 31722-261-21 | Camber PharmaceuticalsIndia | 11 May 2023 |
| 21 capsule in 1 bottle | 69097-384-81 | CiplaIndia | 7 March 2023 |
| 100 capsule in 1 bottle | 43598-514-01 | Dr. Reddy's LaboratoriesIndia | 7 September 2022 |
| 21 capsule in 1 bottle | 43598-514-21 | Dr. Reddy's LaboratoriesIndia | 7 September 2022 |
| 100 capsule in 1 bottle | 63304-045-01 | Sun Pharmaceutical IndustriesIndia | 12 March 2023 |
| 21 capsule in 1 bottle | 63304-045-22 | Sun Pharmaceutical IndustriesIndia | 12 March 2023 |
| 100 capsule in 1 bottle | 47781-487-01 | Alvogen | 6 March 2023 |
| 21 capsule in 1 bottle | 47781-487-77 | Alvogen | 6 March 2023 |
| 21 capsule in 1 bottle | 60219-1718-1 | Amneal Pharmaceuticals NY | 12 February 2025 |
| 100 capsule in 1 bottle | 60219-1718-2 | Amneal Pharmaceuticals NY | 12 February 2025 |
| 21 capsule in 1 bottle | 60505-4536-2 | Apotex | 9 March 2023 |
| 100 capsule in 1 bottle | 73043-042-01 | Devatis | 31 January 2026 |
| 21 capsule in 1 bottle | 73043-042-21 | Devatis | 31 January 2026 |
| 21 capsule in 1 bottle, plastic | 76282-700-47 | Exelan Pharmaceuticals | 10 June 2024 |
| 100 capsule in 1 bottle, plastic | 0378-1942-01 | Mylan Pharmaceuticals | 7 March 2023 |
| 21 capsule in 1 bottle, plastic | 0378-1942-21 | Mylan Pharmaceuticals | 7 March 2023 |
| 21 capsule in 1 bottle | 82293-038-10 | Novugen Pharma | 10 April 2026 |
| 21 capsule in 1 bottle | 0574-1420-21 | Padagis | 31 January 2026 |
| 21 capsule in 1 bottle | 0480-1245-21 | Teva Pharmaceuticals | 8 March 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Lenalidomide 20 mg capsule.
Other strengths and forms of Lenalidomide
Clinical summary
Lenalidomide is a thalidomide analog indicated for the treatment of adult patients with multiple myeloma (MM), in combination with dexamethasone, among other approved uses. It is available as capsules for oral use. MedsAcross supplies Lenalidomide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LenalidomideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Revlimid prescribing information (Celgene) · U.S. National Library of Medicine, DailyMed
- Revlimid: European public assessment report (EPAR) · European Medicines Agency
- Lenalidomide Accord: European public assessment report (EPAR) · European Medicines Agency
Need Lenalidomide 20 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.